台股 » 個股 » 東生華 » 籌碼相關 » 券商分點績效 » 券商分點個股進出

東生華

(8432)
可現股當沖
  • 股價
    63.9
  • 漲跌
    ▲0.1
  • 漲幅
    +0.16%
  • 成交量
    37
  • 產業
    上櫃 生技醫療類股
  • 36人加入追蹤

    立即追蹤

  • 本地時間:13:30

     
東生華 (8432)籌碼相關-兆豐-桃鶯 券商分點個股進出
券商分點績效/獲利分析

透過統計各券商分點在長期買賣某個股的操作績效,來找出真正獲利的贏家所在券商分點,進而追蹤此贏家所操作的股票與軌跡。

兆豐-桃鶯 券商分點個股進出

日期買進張數買進均價賣出張數賣出均價收盤價買賣超60日均量成交佔比 大量交易提示
2024/11/21164.0000.0063.9011480.67%
2024/11/1500.00263.3063.90-2140-1.43%
2024/11/14261.2500.0061.2021381.44%
2024/09/2400.00357.7057.90-3140-2.13%
2024/08/2100.00158.5058.20-1177-0.56%
2024/08/20158.40159.1058.5001800.00%
2024/08/08156.3000.0056.2012010.50%
2024/07/3100.00164.8064.60-1232-0.43%
2024/07/30167.8000.0066.2012310.43%
2024/07/1000.00261.4061.40-2233-0.86%
2024/07/09163.0000.0061.5012320.43%
2024/07/08164.70163.5063.5002290.00%
2024/07/05168.1000.0067.5012220.45%
2024/05/23362.3000.0062.5032691.11%
2024/05/0900.00167.1067.10-1313-0.32%
2024/05/0300.00161.2059.50-1269-0.37%
2024/05/0200.00160.4060.50-1268-0.37%
2024/04/09157.8000.0057.7012580.39%
2024/03/04461.9300.0061.1042261.77%
2024/03/0100.00263.9063.80-2220-0.91%
2024/02/2900.00162.7063.60-1220-0.45%
2024/02/27166.0000.0064.3012160.46%
2024/02/1500.00254.5054.50-2149-1.34%
2024/02/0200.00150.3049.40-1173-0.58%
2024/01/31149.9000.0049.9012150.46%
2024/01/1100.00152.8053.10-1427-0.23%
2024/01/1000.00152.3051.90-1423-0.24%
2024/01/0900.00151.4051.50-1418-0.24%
2024/01/0200.00150.7050.70-1418-0.24%
2023/12/14148.8000.0048.5513950.25%
2023/11/3000.00150.7050.80-1378-0.26%
2023/11/28250.4000.0050.8023750.53%
2023/11/1600.00150.6050.50-1341-0.29%
2023/11/09255.7500.0053.5022980.67%
2023/11/08155.8000.0056.4012780.36%
2023/11/07154.80358.1057.90-2256-0.78%
2023/11/06854.14555.2854.8032091.43%
2023/11/03252.00256.1052.0001730.00%
2023/11/0200.00253.6051.00-2116-1.71%
2023/11/0100.00251.9051.90-277-2.58%
2023/05/2300.00145.5545.15-153-1.87%
2023/05/1900.00144.9044.90-154-1.85%
2023/05/15144.8000.0044.801551.81%
2023/01/06148.15147.7047.250840.00%
2022/09/30143.35143.6043.6003040.00%
2022/09/2800.00145.9542.40-1303-0.33%
2022/09/27145.0500.0045.5513010.33%
2022/09/14249.4000.0050.3022820.71%
2022/09/13149.05350.2350.60-2280-0.71%
2022/09/06149.05148.1048.6502670.00%
2022/09/0500.00350.0249.00-3254-1.18%
2022/09/02147.1500.0047.2512240.45%
2022/08/3100.00147.2547.25-1219-0.46%
2022/08/30145.8500.0045.7512130.47%
2022/07/2500.00447.4547.95-480-4.97%
2022/06/29141.00141.2041.250400.00%
2022/03/0300.00144.2544.35-143-2.30%
2022/03/02143.7000.0044.151432.29%
2022/02/2200.00142.3542.20-137-2.64%
2022/02/18142.2000.0042.351382.57%
2022/01/2500.00442.1042.10-443-9.27%
2021/12/17243.8000.0044.002962.07%
2021/12/15244.1000.0043.952972.06%
2021/11/30144.5500.0044.601971.02%
2021/11/29144.6000.0044.601971.02%
2021/11/26244.5000.0044.652982.03%
2021/04/16451.3000.0051.304884.54%
2021/04/14651.6500.0051.406866.93%
2021/02/2200.00152.7052.10-159-1.69%
2021/02/19152.3000.0052.101561.77%
2019/03/2700.00170.1070.00-162-1.61%
2019/02/21170.2000.0069.501531.89%
2018/12/2800.00172.7072.70-147-2.09%
2018/12/25170.9000.0071.301482.08%
2018/07/1300.00183.1082.70-1345-0.29%
2018/07/10183.4000.0082.7013760.27%
2018/06/0600.00172.3072.10-1421-0.24%
2018/06/04171.1000.0071.2014260.23%
2018/05/0300.00176.5075.40-1428-0.23%
2018/04/251100.0000.0090.0013840.26%
東生華液態切片技術新突破 成功識別92%肺癌基因突變Anue鉅亨-2024/08/26
東生華攜手陽明交大簽署MOU 聚焦人才培育、精準藥物開發Anue鉅亨-2024/07/22
東生華法說會/併購高峰、三大業務加持 今年營收拚增五成達12億UDN聯合新聞網-2024/03/25
東生華 相關文章